Heparin Lawsuit News and Information
Heparin Recall Lawsuits
Beginning around November 2007, the FDA started receiving a large number of reports involving adverse events associated with allergic-type reactions to heparin. Subsequent investigations have uncovered that a large portion of the heparin sold in the United States around this time was contaminated with a fake ingredient. In early 2008, a nationwide Baxter [...]
All Articles Tagged With: "Heparin"
FDA Warns that New Heparin Will be Less Potent to Improve Safety
The FDA has alerted health care professionals that new batches of the blood thinner Heparin will be less potent than previous versions due to new safety standards, which are designed to make it easier for manufacturers to ensure the purity of the drug and help avoid a repeat of the widespread heparin contamination that sickened [...]
Baxter Heparin Recall Lawsuits Scheduled for Trials to Begin November 2010
The first product liability trial over defective batches of the blood thinner heparin, which were used throughout the United States from late 2007 to early 2008 and may have killed 81 people and sickened hundreds more, has been scheduled to begin in November 2010.
Baxter Denies Recent Heparin Problems Linked to Product Quality
Following two patient deaths and serious complications experienced by a third at Beebe Medical Center in Delaware, Baxter International indicates that their investigation has found no evidence of problems with the quality of their heparin premix product that was used with all three patients.
Baxter Heparin Deaths in Delaware Renew Concerns about Blood Thinner
The FDA is investigating two recent deaths linked to the use of Baxter heparin at one hospital in Delaware, raising concerns once again about possible contamination or other manufacturing problems similar to those that caused more than 80 heparin deaths early last year.
Pre-Filled Syringes Shipped by Manufacturer Knowing They Weren’t Sterile
According to federal prosecutors, tainted pre-filled syringes were shipped from a North Carolina plant by AM2PAT, Inc., with knowledge that they were not sterile and could pose a substantial health risk.
Court Order will Help Lawyers Investigate Heparin Lawsuits
The Judge overseeing all federal heparin lawsuits stemming from last year’s recall of contaminated blood thinner, has issued an order which will assist heparin lawyers during their investigation of cases for people who may have died from the counterfeit chemical found in much of the United States’ heparin supply between late 2007 and early 2008. [...]
Innohep Death Risk for Elderly Leads to New Warning
Celgene Corp. sent a letter last week to healthcare providers warning that their blood thinner Innohep may increase the risk of death in elderly patients with kidney problems, recommending that alternative treatments be considered for these patients.
Study Confirms Heparin Reactions Caused by Contaminant
A study published this week by the New England Journal of Medicine confirms that hundreds of heparin reactions and deaths suffered earlier this year were caused by a fake chemical that was found in the blood thinner.
FDA: Innohep Side Effects Could Increase Death Risk for Patients Over 70
The FDA has issued an early communication about an on-going safety review into potential side effects of Innohep, a low-molecular weight heparin. The agency has asked the drug maker to revise the warning label to indicate the Innohep death risk for elderly patients with renal insufficiency could extend to those 70 and older.
Bad Heparin Seized by FDA from Drug Maker in Ohio
At the request of the FDA, U.S. Marshalls seized 11 lots of contaminated heparin yesterday from Celsus Laboratories, Inc. in Cincinnati, Ohio. The bad heparin contained raw ingredients from China which have been found to be tainted with a fake chemical that has already sickened or killed hundreds of people in the United States [...]
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
